The global Slide Staining System Market size is expected to reach USD 8.02 billion by 2028 and register a robust CAGR of 11.2% over the forecast period, according to the latest report by Reports and Data. Steady market revenue growth is majorly attributed to rising demand for advanced equipment in clinical research and diagnostic laboratories, increasing adoption of automated slide stainers, and technological advancements in laboratory instruments used in pathologies. Some other factors include growing emphasis on automation of pathological procedures, urgent need for improved laboratory efficiency and precise results, rising adoption of advanced diagnostic software, and increasing government spending on research development activities in the pharmaceutical and biotechnology sectors. Rapidly increasing geriatric population worldwide, increasing healthcare burden driven by rising prevalence of acute and chronic diseases, and surging healthcare expenditure are other factors expected to continue to support global market growth going ahead.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC])@ https://www.reportsanddata.com/sample-enquiry-form/3970
Slide strainers are devices used to automate the staining process of prepared cytology or histology tissue specimens. These devices diffuse dyes into the specimens through direct staining, indirect staining, mordant staining, or surface adsorption processes. The process of staining plays a vital role in the microscopic study of biological samples as it highlights connective tissue, muscle fibers, and cell populations and organelles. Slide strainers are widely used in cytopathology, histopathology, and hematology and help quantify specific compounds present in biological samples. Increasing adoption of automated slide stainers for automation of the staining process is a significant factor propelling market growth. These devices automate the staining process of hematologic smears, thereby automatically adjusting sample thickness and color intensity. One of the main advantages of automated slide stainers is that more than one staining process can be conducted at a time.
Browse Full Report Description + Research Methodology + Table of Content + Infographics @ https://www.reportsanddata.com/report-detail/slide-stainers-market
Significantly, China's adoption of health insurance and broader healthcare reforms last year effectively created a market of one billion people overnight. However, generic medications account for 76% of the Chinese market, making it difficult for European and American multinationals to capitalize on market prospects.
In the past, developed countries were hesitant to trade in emerging markets, with only a few multinational pharmaceutical companies making acquisitions in Latin America, India, or China. However, with tremendous development potential in the East, major businesses in the pharmaceutical industry should explore acquisitions in China aggressively to gain a presence.
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/3970
Some Key Highlights From the Report:
- Based on product type, the reagents segment is expected to dominate other type segments over the forecast period, and register the highest revenue growth rate. Growth of this segment is supported by rising healthcare burden of chronic and acute diseases, increasing focus on laboratory automation, significant rise in pharmaceutical RD activities, and increased government investments in healthcare infrastructure development.
- Among the end-use segments, the diagnostic centers segment accounted for highest revenue share in 2020 and is projected to maintain its dominance throughout the forecast period. Increasing number of diagnostic centers, rising adoption of automated laboratory instruments in diagnostic centers, and increasing prevalence of acute and chronic diseases is fueling revenue growth of this segment.
- The Slide Staining System Market in North America accounted for over 33% revenue share contribution to the global market in 2020 and is expected to dominate other regional markets over the forecast period. Rising demand for automated laboratory equipment, increasing government funding for research development activities in pharmaceutical and biotechnology sectors, and presence of state-of-the-art laboratory infrastructure are some major factors driving revenue growth of the North America market.
- Major companies in the global Slide Staining System Market are Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Danaher Corporation, BioGenex, Agilent Technologies, Inc., Merck Group, Biocare Medical, Sakura, Hardy Diagnostics, and General Data Company.
For the purpose of this report, the global Slide Staining System Market is segmented based on product type, technology, end-use, and region:
By Product Type (Revenue, USD Billion; 2018-2028)
- Reagents
- Consumables accessories
- Equipment
- Manual slide staining sets
- Automated slide stainers
By Technology (Revenue, USD Billion; 2018-2028)
- Immunohistochemistry
- Hematoxylin and eosin
- In situ hybridization
- Cytology
- Hematology
- Microbiology
- Special stains
By End-use (Revenue, USD Billion; 2018-2028)
- Hospitals clinics
- Diagnostic centers
- Pharmaceutical and biotechnology companies
- Academic and research institutes
- Others
By Region (Revenue, USD Billion; 2018-2028)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Rest of the Asia Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East Africa
- Saudi Arabia
- UAE
- Rest of the Middle East Africa
Growing advancements in medical therapies to drive market growth
The pharmaceutical and healthcare industry is driven by rapid advancements in customized therapies, medical devices, and surgical procedures. Integration of advanced technologies to accelerate research and development and manufacturing and production activities are some other factors driving market growth.
High prices of certain drugs might affect revenue growth
Launch of high-priced drugs to treat rare and chronic diseases and lesser affordability in middle- and low-income regions might limit their adoption and restrain market growth going ahead. In addition, less knowledge and awareness regarding advanced treatment approaches and lower adoption of advanced technologies might further hamper market growth over the forecast period.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W, Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Read the innovative blog at https://www.reportsanddata.com/blogs
Check out our upcoming research report at https://www.reportsanddata.com/upcoming-reports
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update: https://www.youtube.com/channel/UChLqKTFLm6sVBLEUjnadIhQ/video